Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Braz. j. otorhinolaryngol. (Impr.) ; 86(1): 111-118, Jan.-Feb. 2020. tab, graf
Article in English | LILACS | ID: biblio-1089362

ABSTRACT

Abstract Introduction Tranexamic acid is a hemostatic agent, which inhibits fibrin degradation, which may be beneficial in controlling bleeding during surgery. Objectives The purpose of this study was to provide a meta-analysis and review of the effects of tranexamic acid on hemorrhage and surgical fields and side effects on patients during endoscopic sinus surgery. Methods Two authors independently searched six databases (Medline, Scopus, Embase, Web of Science, Google Scholar and Cochrane library) from the start of article collection until July 2018. Postoperative complications such as intraoperative bleeding, operative time, hypotension, nausea, vomiting, and coagulation profile were included in the analysis of tranexamic acid (Treatment Group) and placebo (Control Group) during the operation. Results The amount of blood loss during surgery was statistically lower in the treatment group compared to the placebo group, and the surgical field quality was statistically higher in the treatment group than in the placebo group. On the other hand, there was no significant difference in operation time, hemodynamics, or coagulation profile between groups. In addition, tranexamic acid had no significant effect on vomiting and thrombosis compared to the Control Group. Conclusion This meta-analysis has shown that topical administration of tranexamic acid can reduce the amount of bleeding during surgery and improve the overall quality of the surgery. Hemodynamic instability during surgery, vomiting after surgery, or abnormal clotting profile were not reported. Additional studies are needed to confirm the results of this study because there are fewer studies.


Resumo Introdução O ácido tranexâmico é um agente hemostático, que inibe a degradação da fibrina e pode ser benéfico no controle do sangramento durante a cirurgia. Objetivos Fazer uma metanálise e revisão dos efeitos do ácido tranexâmico na hemorragia e nos campos cirúrgicos e efeitos colaterais em pacientes durante a cirurgia endoscópica do seio nasal. Método Dois autores realizaram independentemente uma busca em seis bancos de dados (Medline, Scopus, Embase, Web of Science, Google Scholar e Cochrane) desde o início da coleta de artigos até julho de 2018. Complicações pós-operatórias como sangramento intraoperatório, tempo operatório, hipotensão, náusea, vômitos e perfil de coagulação foram incluídos na análise do ácido tranexâmico (grupo de tratamento) e placebo (grupo controle) durante a cirurgia. Resultados A quantidade de perda de sangue durante a cirurgia foi estatisticamente menor no grupo de tratamento comparado com o grupo placebo e a qualidade do campo cirúrgico foi estatisticamente maior no grupo de tratamento do que no grupo placebo. Por outro lado, não houve diferença significante no tempo cirúrgico, hemodinâmica ou perfil de coagulação entre os grupos. Além disso, o ácido tranexâmico não teve efeito significante na ocorrência de vômitos e trombose em comparação ao grupo controle. Conclusão Esta metanálise mostrou que a administração tópica de ácido tranexâmico pode reduzir a quantidade de sangramento durante a cirurgia e melhorar a qualidade geral dela. Instabilidade hemodinâmica durante a cirurgia, vômitos após a cirurgia ou perfil de coagulação anormal não foram relatados. Estudos adicionais são necessários para confirmar os resultados desta pesquisa, porque há poucos estudos na literatura.


Subject(s)
Humans , Tranexamic Acid/pharmacology , Epistaxis/drug therapy , Blood Loss, Surgical/prevention & control , Intraoperative Complications/drug therapy , Antifibrinolytic Agents/pharmacology , Tranexamic Acid/administration & dosage , Randomized Controlled Trials as Topic , Administration, Topical , Endoscopy/adverse effects , Nasal Surgical Procedures/adverse effects , Intraoperative Complications/etiology , Anesthesia, General , Antifibrinolytic Agents/administration & dosage
2.
Rev. bras. anestesiol ; 68(1): 42-48, Jan.-Feb. 2018. tab, graf
Article in English | LILACS | ID: biblio-897799

ABSTRACT

Abstract Introduction Shivering, a common intraoperative problem under spinal anesthesia increases the oxygen consumption considerably and is uncomfortable and distressing to the patient, anesthesiologist as well as surgeon. The present study was designed to explore the effectiveness of tramadol, clonidine and dexmedetomidine in the treatment of post spinal anesthesia shivering and to look for their adverse effects. Methods This prospective, randomized, double blinded control study was done on 90 patients who developed shivering under spinal anesthesia. They were randomly allocated into three groups with Group T receiving tramadol 1 mg.kg-1, Group C getting clonidine 1 mcg.kg-1 and Group D patients receiving dexmedetomidine 0.5 mcg.kg-1. The time taken to control shivering, recurrence rate, hemodynamic variables, sedation score and adverse effects were observed. Results Dexmedetomidine was faster in the control of shivering in 5.7 ± 0.79 minutes (min) whereas tramadol took 6.76 ± 0.93 min and clonidine was slower with 9.43 ± 0.93 min. The recurrence rate was much lower in the dexmedetomidine group with 3.3% than for clonidine (10%) and tramadol (23.3%) group. The sedation achieved with dexmedetomidine was better than clonidine and tramadol. The tramadol group had more cases of vomiting (four) and dexmedetomidine group had six cases of hypotension and two cases of bradycardia. Two of the clonidine patients encountered bradycardia and hypotension. Conclusion Dexmedetomidine is better than tramadol and clonidine in the control of shivering because of its faster onset and less recurrence rate. Though complications are encountered in the dexmedetomidine group, they are treatable.


Resumo Introdução O tremor, problema comum no período intraoperatório sob raquianestesia, aumenta consideravelmente o consumo de oxigênio, além de ser desconfortável e angustiante para o paciente, o anestesiologista e o cirurgião. O presente estudo foi concebido para explorar a eficácia de tramadol, clonidina e dexmedetomidina no tratamento de tremores pós-raquianestesia e observar seus efeitos adversos. Métodos Este estudo prospectivo, randômico, controlado e duplo-cego foi feito com 90 pacientes que desenvolveram tremores sob raquianestesia. Os pacientes foram randomicamente alocados em três grupos para receber 1 mg.kg-1 de tramadol (Grupo T), 1 mcg.kg-1 de clonidina (Grupo C) e 0,5 mcg.kg-1 de dexmedetomidina (Grupo D). O tempo necessário para controlar os tremores, a taxa de recorrência, as variáveis hemodinâmicas, os níveis de sedação e os efeitos adversos foram registrados. Resultados Dexmedetomidina foi mais rápida para controlar os tremores, com tempo de 5,7 ± 0,79 minutos (min); o tempo de tramadol foi de 6,76 ± 0,93 min; clonidina foi mais lenta, com tempo de 9,43 ± 0,93 min. A taxa de recorrência foi muito menor no grupo dexmedetomidina (3,3%) do que nos grupos clonidina (10%) e tramadol (23,3%). A sedação obtida com dexmedetomidina foi melhor do que a obtida com clonidina e tramadol. O grupo tramadol teve mais casos de vômito (quatro); o grupo dexmedetomidina teve seis casos de hipotensão e dois casos de bradicardia. Dois pacientes do grupo clonidina apresentaram bradicardia e hipotensão. Conclusão Dexmedetomidina foi melhor do que tramadol e clonidina para o controle de tremores devido ao seu início de ação mais rápido e à taxa de recorrência mais baixa. Embora complicações tenham sido observadas no grupo dexmedetomidina, elas foram tratáveis.


Subject(s)
Humans , Male , Female , Adult , Shivering/drug effects , Tramadol/therapeutic use , Clonidine/therapeutic use , Dexmedetomidine/therapeutic use , Hypnotics and Sedatives/therapeutic use , Intraoperative Complications/drug therapy , Anesthesia, Spinal/adverse effects , Narcotics/therapeutic use , Double-Blind Method , Prospective Studies
3.
Journal of Korean Medical Science ; : 989-996, 2016.
Article in English | WPRIM | ID: wpr-224845

ABSTRACT

Increased intraocular pressure (IOP) during surgery is a risk factor for postoperative ophthalmological complications. We assessed the efficacy of systemically infused dexmedetomidine in preventing the increase in IOP caused by a steep Trendelenburg position, and evaluated the influence of underlying hypertension on IOP during surgery. Sixty patients undergoing laparoscopic surgery in a steep Trendelenburg position were included. Patients in the dexmedetomidine group received a 1.0 µg/kg IV loading dose of dexmedetomidine before anesthesia, followed by an infusion of 0.5 µg/kg/hr throughout the operation. Patients in the saline group were infused with the same volume of normal saline. IOP and ocular perfusion pressure (OPP) were measured 16 times pre- and intraoperatively. In the saline group, IOP increased in the steep Trendelenburg position, and was 11.3 mmHg higher at the end of the time at the position compared with the baseline value (before anesthetic induction). This increase in IOP was attenuated in the dexmedetomidine group, for which IOP was only 4.2 mmHg higher (P < 0.001 vs. the saline group). The steep Trendelenburg position was associated with a decrease in OPP; the degree of decrease was comparable for both groups. In intragroup comparisons between patients with underlying hypertension and normotensive patients, the values of IOP at every time point were comparable. Dexmedetomidine infusion attenuated the increase in IOP during laparoscopic surgery in a steep Trendelenburg position, without further decreasing the OPP. Systemic hypertension did not seem to be associated with any additional increase in IOP during surgery. (Registration at the Clinical Research Information Service of Korea National Institute of Health ID: KCT0001482)


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Dexmedetomidine/administration & dosage , Double-Blind Method , Eye Diseases/surgery , Head-Down Tilt , Hypnotics and Sedatives/administration & dosage , Intraocular Pressure/drug effects , Intraoperative Complications/drug therapy , Laparoscopy , Prospective Studies , Risk Factors , Tonometry, Ocular , Treatment Outcome
4.
Int. braz. j. urol ; 38(3): 405-410, May-June 2012. tab
Article in English | LILACS | ID: lil-643040

ABSTRACT

INTRODUCTION AND OBJECTIVE: Transrectal ultrasound biopsy of prostate is a painful procedure. The introduction of the rectal probe is one of the major contributors to the pain associated with this procedure. Drugs that relax the anal sphincter should theoretically decrease this pain. This study was done to compare the efficacy and safety of two topical medications that relax the anal sphincter, diltiazem and nitroglycerine, in decreasing the pain associated with transrectal ultrasound guided prostate biopsy. MATERIALS AND METHODS: 66 patients who were to undergo their first prostate biopsy were randomized to receive either 2 mL of 2% topical diltiazem or 2 mL of 0.2% topical nitroglycerine or placebo 20 minutes before prostate biopsy. All patients also received 15 mL of intrarectal lignocaine. A 10-point visual analogue score was used to record the pain immediately after the insertion of the probe, during biopsy and at the end of the procedure. RESULTS: The pain scores due to probe insertion, during biopsy and at the end of the procedure in patients who received topical diltiazem or nitroglycerine were significantly lower compared to the placebo group (p < 0.001). There were no significant differences in the pain scores between the patients receiving diltiazem compared to those receiving nitroglycerine. Higher incidence of headache and fall in blood pressure was noted in patients who received nitroglycerine compared to those receiving diltiazem. CONCLUSION:Topical diltiazem and nitroglycerine are equally effective in reducing the pain associated with transrectal prostatic biopsy. Diltiazem is safer compared to nitroglycerine.


Subject(s)
Aged , Humans , Male , Middle Aged , Anesthetics, Local/administration & dosage , Diltiazem/administration & dosage , Endoscopic Ultrasound-Guided Fine Needle Aspiration/adverse effects , Intraoperative Complications/drug therapy , Nitroglycerin/administration & dosage , Pain/drug therapy , Prostate/pathology , Administration, Oral , Administration, Rectal , Endoscopic Ultrasound-Guided Fine Needle Aspiration/methods , Lidocaine/administration & dosage , Pain Measurement , Pain/etiology , Prostate , Time Factors , Treatment Outcome
5.
Arq. bras. oftalmol ; 70(6): 1006-1009, nov.-dez. 2007. ilus
Article in Portuguese | LILACS | ID: lil-474111

ABSTRACT

A cisticercose é uma parasitose causada por ovos de Taenia solium, que pode acometer diversos tecidos como coração, músculo esquelético, cérebro e olhos. Neste estudo será descrito o caso de um paciente de 62 anos do sexo masculino encaminhado com queixa de baixa acuidade visual progressiva no olho direito há dois meses. O exame biomicroscópico e ultra-sonográfico permitiu o diagnóstico ocular de cisticercose intravítrea. Foi realizada cirurgia de vitrectomia via pars plana para remoção do parasita e no intra-operatório ocorreu ruptura do cisto com extravasamento intravítreo. Durante o procedimento foram injetadas 400 microgramas de dexametasona intravítreo e prescrito 60 mg/dia de prednisona via oral por 14 dias. O paciente evoluiu com recuperação visual e acuidade visual final de 20/25, retina aplicada e vítreo claro. Em conclusão, farmacoterapia com corticóide intravítreo associada à terapia com corticóide sistêmico pode ser considerada como alternativa a ser associada para o controle inflamatório após cirurgia vitreorretiniana de cisticercose ocular.


Cysticercosis is a parasitosis caused by Taenia solium eggs that could affect several tissues, such as heart, skeletal muscles, brain and eyes. This study describes the case of a 62-year-old male who complained of progressively loss of vision in his right eye for two months. Slit-lamp and ultrasound exams suggested a diagnosis of intravitreous cysticercosis. The patient underwent pars plana vitrectomy to remove the intravitreous parasite. Intraoperatively the cyst ruptured and leaked into the vitreous cavity. Therefore, 400 µg of intravitreous dexamethasone was injected intraoperatively, and 60 mg/day of prednisone PO was prescribed for 14 days. The post-operative best corrected visual acuity was 20/25, the retina was attached and vitreous remained clear. In conclusion, drug therapy with intravitreous corticosteroids associated with systemic steroids showed to be an alternative approach to control inflammation following vitreoretinal surgery.


Subject(s)
Humans , Male , Middle Aged , Cysticercosis/drug therapy , Eye Infections, Parasitic/drug therapy , Glucocorticoids/therapeutic use , Intraoperative Complications/drug therapy , Vitreous Body , Administration, Oral , Cysticercosis/surgery , Dexamethasone/therapeutic use , Eye Infections, Parasitic/surgery , Prednisolone/therapeutic use , Visual Acuity/drug effects , Visual Acuity/physiology , Vitrectomy/adverse effects , Vitreous Body/parasitology
6.
São Paulo med. j ; 124(6): 340-342, Nov. 7, 2006. ilus
Article in English | LILACS | ID: lil-441174

ABSTRACT

CONTEXT: Laparoscopic adjustable silicone gastric banding (LASGB) is one of the several surgical techniques for treating patients with morbid obesity. Erosion and perforation in the gastric chamber caused by LASGB are rare complications that have already been described. There have not yet been any reports of perforation of the middle esophagus during this procedure. CASE REPORT: The authors describe the case of a patient who presented the complication of very extensive perforation of the middle third of the esophagus following LASGB. This was successfully managed using conservative treatment.


CONTEXTO: Banda gástrica laparoscópica ajustável de silicone (LASGB) é uma das várias técnicas cirúrgicas para o tratamento de pacientes com obesidade mórbida. A erosão e a perfuração para o interior da câmara gástrica causados pela LASGB são complicações raras já descritas. Não se encontram relatos de perfuração do esôfago médio durante esse procedimento. RELATO DE CASO: Descrevemos o caso de uma paciente que apresentou como complicação, uma perfuração extensa do esôfago médio após LASGB, submetida a tratamento conservador com sucesso absoluto.


Subject(s)
Humans , Female , Middle Aged , Esophageal Perforation/drug therapy , Gastroplasty/adverse effects , Laparoscopy/adverse effects , Obesity, Morbid/surgery , Anti-Bacterial Agents/therapeutic use , Ceftriaxone/therapeutic use , Enteral Nutrition , Enzyme Inhibitors/therapeutic use , Esophageal Perforation/etiology , Intraoperative Complications/drug therapy , Metronidazole/therapeutic use , Omeprazole/therapeutic use
8.
Article in English | IMSEAR | ID: sea-38668

ABSTRACT

We conducted a randomized, double blinded, placebo controlled trial to evaluate the effectiveness of EMLA cream together with intraperitoneal lidocaine for pain relief in postpartum tubal ligation. In a factorial designed study, 90 postpartum patients were randomly assigned to have 5 g of EMLA or placebo cream applied to the skin in 2 groups of 45 patients and to have intraperitoneal instillation of 20 ml of either 1 per cent, 2 per cent lidocaine or normal saline in 3 groups of 30 patients. A numerical rating pain score (0-10) was used during skin check, skin infiltration and uterine tube manipulation. The pain scores were significantly lower in the EMLA group as compared with the placebo group during the skin forceps check (p < 0.001) and during local skin infiltration (p < 0.05). The pain scores were also significantly lower during intraabdominal manipulation in the group using either 1 per cent or 2 per cent intraperitoneal lidocaine as compared with the group using normal saline (p < 0.001), but no difference was found between the groups using 1 per cent and 2 per cent lidocaine. IMPLICATIONS: Five g of EMLA cream applied to the skin together with 20 ml of 1 per cent lidocaine instilled into the abdominal cavity effectively decrease intraoperative pain in patients undergoing postpartum tubal sterilization under local anesthesia.


Subject(s)
Adult , Anesthetics, Local/administration & dosage , Chi-Square Distribution , Double-Blind Method , Female , Humans , Injections, Intraperitoneal , Intraoperative Complications/drug therapy , Lidocaine/administration & dosage , Ointments , Pain/drug therapy , Postpartum Period , Pregnancy , Prilocaine/administration & dosage , Statistics, Nonparametric , Sterilization, Tubal , Treatment Outcome
9.
West Indian med. j ; 49(1): 73-5, Mar. 2000.
Article in English | LILACS | ID: lil-291895

ABSTRACT

The intraoperative control of cardiovascular disturbances associated with the resection of phaeochromocytoma is traditionally achieved by the use of deep anaesthesia in conjunction with A and B blockers, calcium antagonists, nitroglycerine or sodium nitroprusside. We report the successful use of magnesium sulphate as adjunctive therapy in the control of the cardiovascular consequences associated with surgical resection of a phaeochromocytoma in a patient.


Subject(s)
Adult , Female , Humans , Pheochromocytoma/surgery , Adrenal Gland Neoplasms/surgery , Hypertension/drug therapy , Intraoperative Complications/drug therapy , Magnesium Sulfate/therapeutic use
10.
Rev. mex. anestesiol ; 18(4): 163-70, oct.-dic. 1995. tab
Article in Spanish | LILACS | ID: lil-164626

ABSTRACT

La Anestesia para el trasplante de Hígado es un desafío para el Anestesiólogo, ya que enfrenta una variedad de cambios en las distintas fases de la cirugía, manejo de transfusión masiva, alteraciones cardio-hemodinámicas, coagulopatías, desequilibrios hidroelectrolítico, ácido base, etc. El anestesiólogo debe de recibir un adiestramiento para el cuidado transoperatorio y desarrollar la habilidad para monitoreo invasivo para esta cirugía de alto grado de complejidad. En el presente artículo se revisan los aspectos fundamentales del manejo Anestésico en el paciente que será sometido a transplante hepático


Subject(s)
Infant , Child, Preschool , Adolescent , Humans , Male , Pancuronium/administration & dosage , Postoperative Complications , Thiopental/administration & dosage , Biliary Atresia/surgery , Vecuronium Bromide/administration & dosage , Fentanyl/administration & dosage , Monitoring, Intraoperative , Liver Transplantation , Drug Monitoring , Hypocalcemia/mortality , Intraoperative Complications/etiology , Intraoperative Complications/drug therapy , Isoflurane/administration & dosage , In Vitro Techniques
12.
Article in English | IMSEAR | ID: sea-42479

ABSTRACT

The 2.5 mg salbutamol in 2.5 ml normal saline (Ventolin nebules) was used in 22 patients with unexpected bronchospasm via a nebulizer connected to an inspired limb of an anaesthetic machine. Recording of cardiovascular effects, specific notes of breath sound according to symptom severity (clinical lung score), arterial blood gases and airway pressure, was made every 5 minutes up to 30 minutes. The PaCO2 decreased and a/A ratio appeared to increase (improved shunt effect) significantly. However, the cardiovascular effects showed no statistical significance. The airway pressure as well as the clinical lung score appeared to decrease significantly to normal limits 20 minutes after the therapy. We conclude that the use of nebulized beta 2 selective bronchodilator is suitable in the treatment of unexpected bronchospasm without any cardiovascular disturbances.


Subject(s)
Administration, Inhalation , Adolescent , Adult , Aged , Airway Resistance , Albuterol/administration & dosage , Anesthesia/adverse effects , Blood Gas Analysis , Bronchial Spasm/drug therapy , Child , Female , Hemodynamics , Humans , Intraoperative Complications/drug therapy , Male , Middle Aged
14.
Rev. cuba. cir ; 25(3): 265-78, mayo-jun. 1986. tab
Article in Spanish | LILACS | ID: lil-103322

ABSTRACT

Se operaron 15 perros utilizados como patrones, a los cuales se les provocaron adherencias intraperitoneales posoperatorias por el método de Thomas, modificado por nosotros. Estos perros fueron divididos en 3 grupos: IA: Se reintervinieron a las 4 semanas; IB: Se reintervinieron a las 8 semanas; IC: La reintervención se efectuó a las 12 semanas. Se utilizó como método profiláctico el uso intraperitoneal de acetato de hidrocortisona a las dosis de 2,5 mg por Kg de peso. Como testigo se hizo otro grupo de 15 perros, divididos en igual forma que el patrón, pero fueron medicamentados. Se exponen los resultados


Subject(s)
Dogs , Animals , Hydrocortisone/therapeutic use , Peritoneal Diseases/drug therapy , Tissue Adhesions/prevention & control , Intraoperative Complications/drug therapy , Intraoperative Complications/prevention & control , Postoperative Complications/drug therapy , Postoperative Complications/prevention & control , Tissue Adhesions/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL